Skip to main content
. Author manuscript; available in PMC: 2022 Apr 1.
Published in final edited form as: Transpl Infect Dis. 2020 Nov 29;23(2):e13504. doi: 10.1111/tid.13504

TABLE 3.

Distribution of PIDDs by serostatus

Diagnosis R(x): N = 70 R(+): N = 10 R(−): N = 10
Defects with poor production of specific IgG
 ZAP70 mutation 2 1§
 CD40 ligand deficiency 4 1
 IKBa deficiency 1
 PIK3CD mutation 1
 STAT3 GOF mutation 1
 IPEX syndrome 1 1
 XLP 3 1§
 SCID 41
 WAS 11
 Cartilage Hair Hypoplasia 2 1§
 CID (not known gene defect) 1
Defects with intact production of specific IgG
 Chediak-Higashi syndrome 1
 Dyskeratosis congenita 1
 C1q deficiency 1
 HLH 1 5 3
 CGD 1 1
 Congenital neutropenia 1
 IL-10R deficiency 1 1

Note: Distribution of PIDDs by serostatus: PIDDs has been divided into two none: defects in production of specific IgG and capable of production of specific IgG.

Abbreviations: CGD, chronic granulomatous diseasCID, combined immunodeficiency; HLH, hemophagocytic lymphohistiocytosis; IPEX, Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome; PIDDs, primar y immunodeficiency disorders; R(−), seronegative; R(+), seropositive; R(x), unknown CMV serostatus; SCID, Severe combined Immunodeficiency; WAS, Wiskott-Aldrich syndrome; XLP, X-linked lymphoproliferative syndrome.

CMV IgG + and no passive immunity.

CMV IgG + while on IVIg.

§

Despite the underlying defect, these patients demonstrated specific antibodies to tetanus, diphtheria, and pneumococcal vaccines.